DEFA14A: Jazz Pharmaceuticals Urges Employee Shareholders to Vote at Upcoming AGM

Jazz Pharmaceuticals encourages its employee shareholders to vote on key proposals at the upcoming Annual General Meeting (AGM) on July 25, 2024.

Summary

• Jazz Pharmaceuticals is reminding its employee shareholders to vote their shares at the upcoming Annual General Meeting (AGM) scheduled for July 25, 2024.
• The company's board of directors and management team recommend voting FOR each of the director nominees.
• They also recommend voting for the frequency option of every 1 YEAR on the non-binding advisory vote on executive compensation.
• Shareholders are encouraged to vote FOR the other four proposals outlined in the proxy statement.
• The record date for shareholders eligible to vote at the AGM was May 29, 2024.
• Shareholders should have received voting instructions from their bank or broker, either electronically or via mail.
• Assistance with voting is available through Alliance Advisors at +1.855.600.8108 or E*Trade at +1.800.838.0908 / +1.650.599.0125.

Sentiment

Score: 7

Explanation: The document has a neutral to positive sentiment. It is a standard communication encouraging shareholder participation, with an emphasis on the importance of voting and expressing gratitude to employees.

Positives

• The company is actively engaging with its employee shareholders to ensure their participation in the AGM.
• Multiple avenues for assistance are provided to shareholders who need help with the voting process, including contact information for Alliance Advisors and E*Trade.

Future Outlook

The document does not contain any specific forward-looking statements regarding financial performance or future business activities beyond the call to vote at the AGM.

Management Comments

• Neena M. Patil, Executive Vice President & Chief Legal Officer, emphasizes the importance of every share and every vote.
• Management encourages shareholders to vote promptly and thanks them for their contributions to the company's growth and success.

Industry Context

This announcement is a standard practice for publicly traded companies to ensure shareholder participation in important corporate governance matters. It reflects the company's commitment to engaging with its shareholders, including its employees who hold company stock.

Comparison to Industry Standards

• Encouraging employee shareholder participation is a common practice among publicly listed companies.
• Many companies use proxy solicitors like Alliance Advisors to assist with shareholder outreach and voting.
• Providing multiple channels for shareholders to obtain assistance with voting is also a standard practice to maximize participation.

Stakeholder Impact

• Shareholders are encouraged to exercise their voting rights.
• Employees who are also shareholders are specifically targeted to participate in the AGM.

Next Steps

• Shareholders are encouraged to vote their shares as soon as possible.
• The company will hold its Annual General Meeting on July 25, 2024.

Key Dates

Keywords

Annual General Meeting, AGM, Shareholders, Proxy Vote, Jazz Pharmaceuticals, Voting, Employee Stock Plan